{"filing":{"accession_number":"0001193125-26-297668","cik":"0001498382","ticker":"HURA","company_name":"TuHURA Biosciences, Inc./NV","form":"8-K","filing_date":"2026-07-07","report_date":null,"primary_document":"hura-20260630.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1498382/000119312526297668/hura-20260630.htm"},"events":[{"id":16540,"run_id":14776,"accession_number":"0001193125-26-297668","anchor_item_number":"2.03","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The Company drew an additional $1.9 million under an existing revolving credit facility on June 30, 2026. While the underlying Loan Agreement was disclosed on April 21, 2026, this Item 2.03 discloses a new direct financial obligation—the incremental draw itself—which creates or increases a debt obligation. This is a material event affecting the Company's capital structure and liquidity position.","company_name":"TuHURA Biosciences, Inc./NV","ticker":"HURA","filing_date":"2026-07-07","form":"8-K","submitted_at":null,"items":[{"id":14676,"accession_number":"0001193125-26-297668","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The Company drew an additional $1.9 million under an existing revolving credit facility on June 30, 2026. While the underlying Loan Agreement was disclosed on April 21, 2026, this Item 2.03 discloses a new direct financial obligation—the incremental draw itself—which creates or increases a debt obligation. This is a material event affecting the Company's capital structure and liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T21:31:35.925654+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14676,"accession_number":"0001193125-26-297668","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The Company drew an additional $1.9 million under an existing revolving credit facility on June 30, 2026. While the underlying Loan Agreement was disclosed on April 21, 2026, this Item 2.03 discloses a new direct financial obligation—the incremental draw itself—which creates or increases a debt obligation. This is a material event affecting the Company's capital structure and liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T21:31:35.925654+00:00","company_name":"TuHURA Biosciences, Inc./NV","ticker":"HURA","filing_date":"2026-07-07"}]}